Thermo Fisher Scientific (TMO) Tops Q2 EPS by 10c

Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $1.72, $0.10 better than the analyst estimate of $1.62. Revenue for the quarter came in at $4.32 billion versus the consensus estimate of $4.25 billion.

Thermo Fisher Scientific sees FY2014 EPS of $6.85-$6.97, versus prior guidance of $6.8-$6.95 and the consensus of $6.9. Thermo Fisher Scientific sees FY2014 revenue of $16.86-16.98 billion, versus prior guidance of $16.84-17.00 billion and the consensus of $16.94 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

You May Also Be Interested In

• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
• LENSAR, Inc. (LNSR) Tops Q2 EPS by 31c